This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Healthcare and life sciences

Healthcare and life sciencesHealthcare refers to the treatment and management of illness and the preservation of health through services offered by medical, dental, complementary and alternative medicine as well as pharmaceutical, nursing and related health professions.

Life sciences concern the structure and organisation of living organisms, their life processes, their relationships to each other and their environment. This field encompasses companies and institutions in the areas of biotechnology, pharmaceuticals, biomedical technologies, life systems technologies, food processing as well as environmental and biomedical devices.

We provide services to clients operating in a variety of domains within the healthcare and life sciences industry including:

  • CFO services
  • Corporate social responsibility
  • Human capital advisory services
  • Internal audit/Risk management
  • IT services
  • Learning and education
  • Marketing and communication
  • Organisational transformation
  • Partnerships
  • Patient experience
  • Quality management
  • Tax services



  • Luc Brucher
    Partner - Healthcare Leader
  • Karine Pontet
    Directeur - Human Capital Advisory/Transformation

More Learn more

  • Deloitte recognised as 'Best Healthcare Advisory Firm - Strategy' - 20/06/2014
    During the very first Healthcare Summit, held on 5 June 2014, Deloitte Luxembourg was awarded 'Best Healthcare Advisory Firm - Strategy'.
  • Re-engineer your supply chain to save lives | Whitepaper
    Healthcare organisations across the globe are struggling to provide the right drug in the right doses to the right patient across the right route, at the right time.
  • Measuring the return from pharmaceutical innovation 2013 | Whitepaper
    This Deloitte report is the fourth in an annual series exploring the pharmaceutical industry’s performance in generating a return from its investment in new product innovation.
  • 2014 Global life sciences outlook | Whitepaper
    The report outlines the top issues facing global life sciences stakeholders, provides a snapshot of activity in a number of geographic markets, and suggests considerations.



Stay connected:
Get connected
Share your comments
More on Deloitte Luxembourg
Learn about our site

Recently published